Roger Stupp

  • 41274 Citations
1990 …2023
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1990 2020

Filter
Editorial
2015
29 Citations (Scopus)

Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?

Hegi, M. E. & Stupp, R., Nov 2015, In : Neuro-oncology. 17, 11, p. 1425-1427 3 p.

Research output: Contribution to journalEditorial

temozolomide
DNA Modification Methylases
DNA Repair Enzymes
Tumor Suppressor Proteins
Dacarbazine
2014
12 Citations (Scopus)

Questions regarding the optimal use of bevacizumab in glioblastoma: A moving target

Stupp, R. & Weller, M., Jun 2014, In : Neuro-oncology. 16, 6, p. 765-767 3 p.

Research output: Contribution to journalEditorial

Antibodies, Monoclonal, Humanized
Angiogenesis Inhibitors
Glioblastoma
Brain Neoplasms
Bevacizumab
2012

Prime time for molecular marker diagnostics in neuro-oncology

Weller, M. & Stupp, R., Dec 1 2012, In : Current Opinion in Neurology. 25, 6, p. 743-744 2 p.

Research output: Contribution to journalEditorial

Alkylating Antineoplastic Agents
DNA Modification Methylases
DNA Repair Enzymes
Tumor Suppressor Proteins
Combined Modality Therapy
2011
1 Citation (Scopus)

Clinical trials in neuro-oncology: One step forward, two steps back?

Weller, M. & Stupp, R., Dec 1 2011, In : Current Opinion in Neurology. 24, 6, p. 597-598 2 p.

Research output: Contribution to journalEditorial

Medical Oncology
Neurology
Brain Neoplasms
Glioma
Research Design

Editorial introductions

Weller, M., Stupp, R., Ratan, R., Goldfine, A. & Miller, B. L., Dec 1 2011, In : Current Opinion in Neurology. 24, 6

Research output: Contribution to journalEditorial

2010

Current Opinion in Neurology: Editorial introductions

Stupp, R., Weller, M., Vuadens, P. & Hodges, J., Dec 2010, In : Current Opinion in Neurology. 23, 6, p. vii-viii

Research output: Contribution to journalEditorial

Neurology
18 Citations (Scopus)

Neuro-oncology, a decade of temozolomide and beyond

Stupp, R., Hegi, M. & Weller, M., Nov 1 2010, In : Expert review of anticancer therapy. 10, 11, p. 1675-1677 3 p.

Research output: Contribution to journalEditorial

temozolomide
Dacarbazine
Brain Neoplasms
Glioma
Antineoplastic Agents

Targeted therapies on the horizon for malignant glioma

Hofer, S. & Stupp, R., Sep 1 2010, In : Targeted Oncology. 5, 3, p. 157-160 4 p.

Research output: Contribution to journalEditorial

Investigational Drugs
Brain Neoplasms
Glioma
Antineoplastic Agents
Therapeutics
2009

Current Opinion in Neurology: Editorial introductions

Dobkin, B., Bottini, G., Stupp, R. & Weller, M., Nov 1 2009, In : Current Opinion in Neurology. 22, 6, p. vii-viii

Research output: Contribution to journalEditorial

Neurology
6 Citations (Scopus)

Editorial: Approval of new drugs for glioblastoma

Weller, M. & Stupp, R., Nov 1 2009, In : Current Opinion in Neurology. 22, 6, p. 617-618 2 p.

Research output: Contribution to journalEditorial

Drug Approval
United States Food and Drug Administration
Glioblastoma
Antineoplastic Agents
2008
4 Citations (Scopus)

Management of malignant glioma - Quo vadis?

Stupp, R. & Hottinger, A. F., Jun 1 2008, In : Onkologie. 31, 6, p. 300-302 3 p.

Research output: Contribution to journalEditorial

Alkylating Antineoplastic Agents
Dacarbazine
Adjuvant Chemotherapy
Brain Neoplasms
Glioma
2007
106 Citations (Scopus)

Integrin inhibitors reaching the clinic

Stupp, R. & Ruegg, C., May 1 2007, In : Journal of Clinical Oncology. 25, 13, p. 1637-1638 2 p.

Research output: Contribution to journalEditorial

Drug Dose Response Relationship
Growth Substances
Phase II Clinical Trials
Clinical Trials, Phase I
Snake Venoms
43 Citations (Scopus)

Methylguanine methyltransferase testing in glioblastoma: When and how?

Stupp, R. & Hegi, M. E., Apr 20 2007, In : Journal of Clinical Oncology. 25, 12, p. 1459-1460 2 p.

Research output: Contribution to journalEditorial

O(6)-Methylguanine-DNA Methyltransferase
Dacarbazine
Neoplasm Staging
Methyltransferases
Glioblastoma
2005
66 Citations (Scopus)

The role of radio- and chemotherapy in glioblastoma

Stupp, R. & Weber, D. C., Jun 1 2005, In : Onkologie. 28, 6-7, p. 315-317 3 p.

Research output: Contribution to journalEditorial

Computer-Assisted Radiotherapy Planning
Radiation Dose-Response Relationship
Adjuvant Chemotherapy
Glioblastoma
Brain Neoplasms
2003
16 Citations (Scopus)

Promises and controversies in the management of low-grade glioma

Stupp, R. & Baumert, B. G., Dec 1 2003, In : Annals of Oncology. 14, 12, p. 1695-1696 2 p.

Research output: Contribution to journalEditorial

Alkylating Antineoplastic Agents
Combined Modality Therapy
Dacarbazine
Phase II Clinical Trials
Neoplasm Staging
1999
2 Citations (Scopus)

Little to learn from phase II trials in small-cell lung cancer

Leyvraz, S. & Stupp, R., Oct 25 1999, In : Annals of Oncology. 10, 9, p. 1007-1009 3 p.

Research output: Contribution to journalEditorial

Antineoplastic Combined Chemotherapy Protocols
Hematopoietic Cell Growth Factors
Combined Modality Therapy
Phase II Clinical Trials
Small Cell Carcinoma
1994

Introduction

Samuels, B. L., Stupp, R. & Ultmann, J. E., Jan 1 1994, In : Annals of Oncology. 5, SUPPL. 1, p. 5-6 2 p.

Research output: Contribution to journalEditorial

The Lugano International Conferences on Malignant Lymphoma, 1981-1993

Samuels, B. L., Stupp, R. & Ultmann, J. E., Feb 8 1994, In : Annals of Oncology. 5, SUPPL. 1, p. 1-4 4 p.

Research output: Contribution to journalEditorial

20th Century History
Switzerland
Lymphoma